146 related articles for article (PubMed ID: 26024025)
41. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
Borrego Utiel FJ; Bravo Soto JA; Merino Pérez MJ; González Carmelo I; López Jiménez V; García Álvarez T; Acosta Martínez Y; Mazuecos Blanca MA
Nefrologia; 2015; 35(4):363-73. PubMed ID: 26306956
[TBL] [Abstract][Full Text] [Related]
42. 2,3,5,4'-Tetrahydroxystilbene-2-O-
Ling S; Duan J; Ni R; Xu JW
Oxid Med Cell Longev; 2016; 2016():3128235. PubMed ID: 27885332
[TBL] [Abstract][Full Text] [Related]
43. The secreted Klotho protein restores phosphate retention and suppresses accelerated aging in Klotho mutant mice.
Chen TH; Kuro-O M; Chen CH; Sue YM; Chen YC; Wu HH; Cheng CY
Eur J Pharmacol; 2013 Jan; 698(1-3):67-73. PubMed ID: 23041151
[TBL] [Abstract][Full Text] [Related]
44. Effect of total parathyroidectomy and uremia on the chemical composition of bone, skin and aorta in the rat.
Bernstein DS; Pletka P; Hattner RS; Hampers CL; Merrill JP
Isr J Med Sci; 1971 Mar; 7(3):513-4. PubMed ID: 5567540
[No Abstract] [Full Text] [Related]
45. Indoxyl Sulfate Enhance the Hypermethylation of Klotho and Promote the Process of Vascular Calcification in Chronic Kidney Disease.
Chen J; Zhang X; Zhang H; Liu T; Zhang H; Teng J; Ji J; Ding X
Int J Biol Sci; 2016; 12(10):1236-1246. PubMed ID: 27766038
[TBL] [Abstract][Full Text] [Related]
46. Decreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice.
Yu J; Deng M; Zhao J; Huang L
Biochem Biophys Res Commun; 2010 Jan; 391(1):261-6. PubMed ID: 19912987
[TBL] [Abstract][Full Text] [Related]
47. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism.
Albuquerque RFC; Carbonara CEM; Martin RCT; Dos Reis LM; do Nascimento CP; Arap SS; Moysés RMA; Jorgetti V; Montenegro FLM; de Oliveira RB
Surgery; 2018 Feb; 163(2):381-387. PubMed ID: 29146232
[TBL] [Abstract][Full Text] [Related]
48. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
[TBL] [Abstract][Full Text] [Related]
49. The role of the anti-ageing protein Klotho in vascular physiology and pathophysiology.
Mencke R; Hillebrands JL;
Ageing Res Rev; 2017 May; 35():124-146. PubMed ID: 27693241
[TBL] [Abstract][Full Text] [Related]
50. Paricalcitol and endothelial function in chronic kidney disease trial.
Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F
Hypertension; 2014 Nov; 64(5):1005-11. PubMed ID: 25259743
[TBL] [Abstract][Full Text] [Related]
51. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
Latus J; Lehmann R; Roesel M; Fritz P; Braun N; Ulmer C; Steurer W; Biegger D; Ott G; Dippon J; Alscher MD; Kimmel M
Kidney Blood Press Res; 2013; 37(1):84-94. PubMed ID: 23552627
[TBL] [Abstract][Full Text] [Related]
52. Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease.
Ritter C; Miller B; Coyne DW; Gupta D; Zheng S; Brown AJ; Slatopolsky E
Kidney Int; 2017 Nov; 92(5):1217-1222. PubMed ID: 28750928
[TBL] [Abstract][Full Text] [Related]
53. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
Wang X; Sun B; Zhou F; Hu J; Yu X; Peng T
Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
[TBL] [Abstract][Full Text] [Related]
54. Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism.
Cozzolino M; Brancaccio D
Expert Opin Pharmacother; 2008 Apr; 9(6):947-54. PubMed ID: 18377338
[TBL] [Abstract][Full Text] [Related]
55. [The couple fibroblast growth factor 23 (FGF23)/Klotho].
Prié D;
Ann Biol Clin (Paris); 2015; 73(3):299-304. PubMed ID: 26069066
[TBL] [Abstract][Full Text] [Related]
56. N2-carboxyethyl-2'-deoxyguanosine, a DNA glycation marker, in kidneys and aortas of diabetic and uremic patients.
Li H; Nakamura S; Miyazaki S; Morita T; Suzuki M; Pischetsrieder M; Niwa T
Kidney Int; 2006 Jan; 69(2):388-92. PubMed ID: 16408131
[TBL] [Abstract][Full Text] [Related]
57. Decreased parathyroid Klotho expression is associated with persistent hyperparathyroidism after kidney transplantation.
Hong YA; Choi DE; Lim SW; Yang CW; Chang YK
Transplant Proc; 2013 Oct; 45(8):2957-62. PubMed ID: 24157012
[TBL] [Abstract][Full Text] [Related]
58. Metabolic acidosis and vascular calcification: using blueprints from bone to map a new venue for vascular research.
Al-Aly Z
Kidney Int; 2008 Feb; 73(4):377-9. PubMed ID: 18235519
[TBL] [Abstract][Full Text] [Related]
59. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium.
Cozzolino M; Lu Y; Finch J; Slatopolsky E; Dusso AS
Kidney Int; 2001 Dec; 60(6):2109-17. PubMed ID: 11737585
[TBL] [Abstract][Full Text] [Related]
60. Expression of the calcium receptor CaR in the parathyroid of secondary hyperparathyroidism patients.
Wang NN; Wang XY; Peng T; Wu HF; Hu JM; Zhao WH; Yu XB
Chin Med J (Engl); 2004 Sep; 117(9):1408-10. PubMed ID: 15377437
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
